Efficacy and Safety of Digital Therapeutic in Adults With Prediabetes

Conditions: PreDiabetes

Sex: All

Ages: 18 Years – N/A

Phase: NA

Enrollment: 56

Sponsor: Tesu Saglik Teknolojileri A.S.

Location: Turkey

Summary

The study aims to evaluate the efficacy and safety of a digital therapeutic (TH-001) for adult individuals with prediabetes.

Eligibility Criteria

Inclusion Criteria:Being diagnosed with prediabetes according to the ADA Prediabetes Diagnostic Criteria (the presence of at least one of the following criteria is sufficient for diagnosis: FBG 100 - 125 mg/dL, OGTT 2 hour BG: 140 - 199 mg/dL, HbA1c: 5.7% - 6.4)Not using medication for the treatment of prediabetes, and if so, taking a break for at least two weeksHaving a smartphone with an iOS or Android operating systemBeing able to use a mobile applicationExclusion Criteria:Being diagnosed with diabetes mellitusHaving a disease that can cause prediabetesTaking medication that may cause prediabetes

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05668819). StuddyBuddy aggregates publicly available trial information.